{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:50:04Z","timestamp":1786740604547,"version":"build-2736575974"},"reference-count":52,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21808226"],"award-info":[{"award-number":["21808226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21821005"],"award-info":[{"award-number":["21821005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970872"],"award-info":[{"award-number":["31970872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Naturally occurring self-assembling ferritin nanoparticles have become widely appreciated for vaccine design. In this study, an apoferritin (AFt) nanocage was used as a carrier to construct a biomimetic influenza vaccine by encapsulating a conserved internal nucleoprotein (NP) antigen peptide inside the nanocage, followed by chemically conjugating the surface antigen hemagglutinin (HA) protein on the outer surface of the AFt. Benefiting from the excellent thermal stability and thermallyassociated structural flexibility of the AFt nanocages, a novel temperature shift based encapsulation process was proposed and proved efficient for encapsulation of the NP peptides. On average, about 18 NPs were encapsulated and 1.6 HA antigens were conjugated in each of the HA-AFt+NP dual-antigen influenza vaccines. Upon immunization in mice, the HA-AFt+NP vaccine elicited both HA and NP-specific antibodies, and conferred complete protection against a lethal infection of both homologous PR8 H1N1 and heterologous A\/FM\/1\/47 (FM1, H1N1) strains, while the HA-AFt conjugate vaccine without encapsulated NP antigen only conferred 60% protection against the FM1 H1N1 viral challenge. The potential cross-protective effect of the HA-AFt+NP vaccine was further demonstrated by significant specific hemagglutination inhibition (HAI) titers in serum of the immunized mice against heterologous A\/Hong Kong\/4801\/2014 (H3N2) viral strain, which was about 3-fold of that induced by HA antigen and 2-fold of the HA-AFt conjugate vaccine. This biomimetic HA-AFt+NP conjugate vaccine, therefore, may represent a new strategy for developing a potential universal influenza vaccine without the need of any adjuvant, and further broaden the application of AFt nanocages in the areas of vaccine development and delivery system.<\/jats:p>","DOI":"10.1021\/acs.bioconjchem.0c00308","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T14:48:30Z","timestamp":1594997310000},"page":"1948-1959","source":"Crossref","is-referenced-by-count":24,"title":["An Apoferritin\u2013Hemagglutinin Conjugate Vaccine\nwith Encapsulated Nucleoprotein Antigen Peptide from Influenza Virus\nConfers Enhanced Cross Protection"],"prefix":"10.1021","volume":"31","author":[{"given":"Jiangxue","family":"Wei","sequence":"first","affiliation":[{"name":"Chinese Academy of Sciences , , ,","place":["Beijing, PR China, 100190"]},{"name":"University of Chinese Academy of Sciences , ,","place":["Beijing, PR China, 100049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences , , ,","place":["Beijing, PR China, 100190"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences , , ,","place":["Beijing, PR China, 100190"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-5556","authenticated-orcid":true,"given":"Guanghui","family":"Ma","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences , , ,","place":["Beijing, PR China, 100190"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Su","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences , , ,","place":["Beijing, PR China, 100190"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5793-5286","authenticated-orcid":true,"given":"Songping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences , , ,","place":["Beijing, PR China, 100190"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"2026081416074193300_cit1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.immunol.15.1.235","article-title":"Neutralizing\nantiviral B cell responses","volume":"15","author":"Bachmann","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"2026081416074193300_cit2","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.3390\/ijms12085406","article-title":"Self-assembly in\nthe ferritin nano-cage protein superfamily","volume":"12","author":"Zhang","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"2026081416074193300_cit3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/255653a0","article-title":"Structure of horse-spleen apoferritin\nat 6-a resolution","volume":"255","author":"Hoare","year":"1975","journal-title":"Nature"},{"key":"2026081416074193300_cit4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity\nof a peptide epitope after fusion to hepatitis B core protein","volume":"330","author":"Clarke","year":"1987","journal-title":"Nature"},{"key":"2026081416074193300_cit5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/ind.2006.2.143","article-title":"Ferritin nanoparticle technology:\nA new platform for antigen presentation and vaccine development","volume":"2","author":"Li","year":"2006","journal-title":"Ind. Biotechnol."},{"key":"2026081416074193300_cit6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1021\/acs.bioconjchem.8b00004","article-title":"Ferritin nanocages with biologically orthogonal conjugation\nfor vascular targeting and imaging","volume":"29","author":"Khoshnejad","year":"2018","journal-title":"Bioconjugate\nChem."},{"key":"2026081416074193300_cit7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit\nbroadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"2026081416074193300_cit8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.aan7961","article-title":"Can we beat influenza?","volume":"357","author":"Zhang","year":"2017","journal-title":"Science"},{"key":"2026081416074193300_cit9","doi-asserted-by":"publisher","first-page":"1870056","DOI":"10.1002\/smll.201870056","article-title":"Intranasal nanovaccine\nconfers homo- and hetero-subtypic influenza\nprotection","volume":"14","author":"Qi","year":"2018","journal-title":"Small"},{"key":"2026081416074193300_cit10","doi-asserted-by":"publisher","first-page":"02810","DOI":"10.1128\/mBio.02810-18","article-title":"Design of nanoparticulate\ngroup 2 influenza virus hemagglutinin stem antigens that activate\nunmutated ancestor B cell receptors of broadly neutralizing antibody\nlineages","volume":"10","author":"Corbett","year":"2019","journal-title":"mBio"},{"key":"2026081416074193300_cit11","unstructured":"NIH\n          . NIH begins first-in-human trial\nof a universal influenza\nvaccine candidate. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-begins-first-human-trial-universal-influenza-vaccine-candidate (accessed April 2019)."},{"key":"2026081416074193300_cit12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum\nneutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026081416074193300_cit13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature11371","article-title":"Structural and genetic\nbasis for development of broadly neutralizing influenza antibodies","volume":"489","author":"Lingwood","year":"2012","journal-title":"Nature"},{"key":"2026081416074193300_cit14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1178258","article-title":"Hemagglutinin receptor binding avidity drives\ninfluenza A virus antigenic drift","volume":"326","author":"Hensley","year":"2009","journal-title":"Science"},{"key":"2026081416074193300_cit15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-981-10-8456-0_5","article-title":"Structure and function of influenza virus ribonucleoprotein","volume-title":"Subcellular Biochemistry. Vol. 88: Virus Protein and\nNucleoprotein Complexes","author":"Lo","year":"2018"},{"key":"2026081416074193300_cit16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein\nis a major target antigen for cross-reactive anti-influenza A virus\ncytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc. Natl. Acad. Sci.\nU. S. A."},{"key":"2026081416074193300_cit17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4161\/hv.7.4.13845","article-title":"Highly conserved influenza A sequences\nas T cell epitopes-based vaccine targets to address the viral variability","volume":"7","author":"Tan","year":"2011","journal-title":"Hum. Vaccines"},{"key":"2026081416074193300_cit18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fmicb.2019.00344","article-title":"Inhibition of influenza A virus replication\nby TRIM14 via its multifaceted protein-protein interaction with NP","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Microbiol."},{"key":"2026081416074193300_cit19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1098\/rstb.1984.0046","article-title":"Ferritin: design and formation of\nan iron-storage molecule","volume":"304","author":"Ford","year":"1984","journal-title":"Philos. Trans. R.\nSoc London, Ser. B"},{"key":"2026081416074193300_cit20","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1021\/bm200026v","article-title":"pH-dependent structures of ferritin and apoferritin in solution:\ndisassembly and reassembly","volume":"12","author":"Kim","year":"2011","journal-title":"Biomacromolecules"},{"key":"2026081416074193300_cit21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-40388-x","article-title":"Thermally-responsive\nvirus-like particle for targeted delivery of cancer drug","volume":"9","author":"Thong","year":"2019","journal-title":"Sci. Rep."},{"key":"2026081416074193300_cit22","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.2217\/nnm-2018-0259","article-title":"Preparation,\nstructure, cytotoxicity and mechanism of action of ferritin-Pt\u00ad(II)\nterpyridine compound nanocomposites","volume":"13","author":"Ferraro","year":"2018","journal-title":"Nanomedicine"},{"key":"2026081416074193300_cit23","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1002\/adma.201400914","article-title":"Dye-loaded\nferritin nanocages for multimodal imaging and photothermal\ntherapy","volume":"26","author":"Huang","year":"2014","journal-title":"Adv. Mater."},{"key":"2026081416074193300_cit24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2217\/nnm.14.67","article-title":"Synthetic and bioinspired\ncage nanoparticles for drug delivery","volume":"9","author":"Deshayes","year":"2014","journal-title":"Nanomedicine"},{"key":"2026081416074193300_cit25","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1021\/nn305791q","article-title":"RGD-modified\napoferritin nanoparticles for efficient drug delivery to tumors","volume":"7","author":"Zhen","year":"2013","journal-title":"ACS Nano"},{"key":"2026081416074193300_cit26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1006\/abbi.1996.0007","article-title":"Thermal stability of horse spleen\napoferritin and human recombinant H apoferritin","volume":"325","author":"Stefanini","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"2026081416074193300_cit27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.str.2009.12.014","article-title":"P22 coat\nprotein structures reveal a novel mechanism for capsid maturation:\nstability without auxiliary proteins or chemical crosslinks","volume":"18","author":"Parent","year":"2010","journal-title":"Structure"},{"key":"2026081416074193300_cit28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.chroma.2018.10.050","article-title":"A two-step heat\ntreatment of cell\ndisruption supernatant enables efficient removal of host cell proteins\nbefore chromatographic purification of HBc particles","volume":"1581","author":"Li","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"2026081416074193300_cit29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue\nsulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"2026081416074193300_cit30","doi-asserted-by":"publisher","first-page":"12278","DOI":"10.1039\/c3nr04268e","article-title":"Antibody-drug\nconjugates: targeting melanoma with cisplatin encapsulated in protein-cage\nnanoparticles based on human ferritin","volume":"5","author":"Falvo","year":"2013","journal-title":"Nanoscale"},{"key":"2026081416074193300_cit31","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/smll.200801602","article-title":"Protein-based\nnanomedicine platforms for drug delivery","volume":"5","author":"MaHam","year":"2009","journal-title":"Small"},{"key":"2026081416074193300_cit32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2016.03.001","article-title":"Engineering\nvirus-like particles\nas vaccine platforms","volume":"18","author":"Frietze","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"2026081416074193300_cit33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1128\/JVI.76.1.432-435.2002","article-title":"Increased\nefficacy of the immunoglobulin G2a subclass\nin antibody-mediated protection against lactate dehydrogenase-elevating\nvirus-induced polioencephalomyelitis revealed with switch mutants","volume":"76","author":"Markine-Goriaynoff","year":"2002","journal-title":"J. Virol."},{"key":"2026081416074193300_cit34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction\nof murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J. Exp. Med."},{"key":"2026081416074193300_cit35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin\nG1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"2026081416074193300_cit36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling\nprotein nanoparticles in the design of vaccines","volume":"14","author":"Lopez-Sagaseta","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2026081416074193300_cit37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/nnm.14.200","article-title":"Nanomaterials for\nenhanced immunity\nas an innovative paradigm in nanomedicine","volume":"10","author":"Seth","year":"2015","journal-title":"Nanomedicine"},{"key":"2026081416074193300_cit38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle\nvaccine elicits a therapeutic antibody\nresponse against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"2026081416074193300_cit39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1166\/jbn.2012.1406","article-title":"A novel protein-based\nanticancer\ndrug encapsulating nanosphere: apoferritin-doxorubicin complex","volume":"8","author":"Kilic","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"2026081416074193300_cit40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26772-z","article-title":"Prostate-specific membrane antigen-targeted site-directed\nantibody-conjugated apoferritin nanovehicle favorably influences in\nvivo side effects of doxorubicin","volume":"8","author":"Dostalova","year":"2018","journal-title":"Sci. Rep."},{"key":"2026081416074193300_cit41","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.nano.2016.03.007","article-title":"Biocompatibility\nof ferritin-based\nnanoparticles as targeted MRI contrast agents","volume":"12","author":"Charlton","year":"2016","journal-title":"Nanomedicine"},{"key":"2026081416074193300_cit42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: molecular properties, iron storage function\nand cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim. Biophys. Acta,\nBioenerg."},{"key":"2026081416074193300_cit43","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.4049\/jimmunol.177.5.3406","article-title":"CD100 enhances dendritic\ncell and CD4\u00ad(+) cell activation leading to pathogenetic humoral responses\nand immune complex glomerulonephritis","volume":"177","author":"Li","year":"2006","journal-title":"J. Immunol."},{"key":"2026081416074193300_cit44","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2217\/nnm.14.119","article-title":"Apoferritin\napplications in nanomedicine","volume":"9","author":"Heger","year":"2014","journal-title":"Nanomedicine"},{"key":"2026081416074193300_cit45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jconrel.2013.03.008","article-title":"PEG as a spacer arm markedly increases\nthe immunogenicity of meningococcal group Y polysaccharide conjugate\nvaccine","volume":"172","author":"Huang","year":"2013","journal-title":"J. Controlled Release"},{"key":"2026081416074193300_cit46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition\nof a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"2026081416074193300_cit47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","article-title":"Double-layered protein nanoparticles induce broad protection\nagainst divergent influenza A viruses","volume":"9","author":"Deng","year":"2018","journal-title":"Nat.\nCommun."},{"key":"2026081416074193300_cit48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10875-011-9632-5","article-title":"Safety and immunogenicity of multimeric-001--a\nnovel universal influenza vaccine","volume":"32","author":"Atsmon","year":"2012","journal-title":"J. Clin.\nImmunol."},{"key":"2026081416074193300_cit49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-10661-8","article-title":"Quantification\nof epitope abundance reveals the effect of direct\nand cross-presentation on influenza CTL responses","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"key":"2026081416074193300_cit50","doi-asserted-by":"publisher","first-page":"E7758","DOI":"10.1073\/pnas.1805713115","article-title":"Heterosubtypic influenza\nprotection elicited\nby double-layered polypeptide nanoparticles in mice","volume":"115","author":"Deng","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026081416074193300_cit51","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1016\/j.biomaterials.2012.03.041","article-title":"Role of\nsustained antigen release from nanoparticle\nvaccines in shaping the T cell memory phenotype","volume":"33","author":"Demento","year":"2012","journal-title":"Biomaterials"},{"key":"2026081416074193300_cit52","volume-title":"WHO\nglobal influenza surveillance network: manual for the laboratory diagnosis\nand virological surveillance of influenza","author":"WHO","year":"2011"}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.bioconjchem.0c00308","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/31\/8\/1948\/5888172\/bc0c00308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/31\/8\/1948\/5888172\/bc0c00308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:24:06Z","timestamp":1786739046000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bcches\/article\/31\/8\/1948\/588574\/An-Apoferritin-Hemagglutinin-Conjugate-Vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,7,17]]},"published-print":{"date-parts":[[2020,8,19]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00308","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}